Winner Profile
Stefan Schulze
CEO, formerly at Vifor Pharma
Industry: Pharmaceuticals
Company size: Large
Published: 2021-07-25
Is Vifor Pharma a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Stefan Schulze (for his work at Vifor Pharma) earned the following Obermatt pins for the management performance.
Obermatt accolades Stefan Schulze
| Year | Pin | Category |
|---|---|---|
| 2020 |  |
Investment Performance |
|
Operating Performance | |
|
Combined Performance | |
 |
Growth Performance | |
| 2019 |  |
Operating Performance |
 |
Growth Performance | |
|
Combined Performance |
Stefan Schulze is not included in a current Obermatt competition.
Performance Overview Stefan Schulze
In summary, Stefan Schulze obtained the following performances in the individual Obermatt categories over three participations in the Obermatt rankings (averages of all evaluated rankings are shown):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 78 in Combined Performance indicates that Stefan Schulze was better than 78% of all other CEOs that were analyzed as part of the Mid-sized Companies – Switzerland for three participations in Obermatt CEO competitions. Stefan Schulze’s average ranking can be found in the Multi-Year Rankings for Mid-sized Companies - Switzerland.